U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07073677) titled 'A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients' on July 09.

Brief Summary: This study aims to evaluate the efficacy and safety of IN-115314 Ointment in mild to moderate atopic dermatitis adult patients

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Mild to Moderate Atopic Dermatitis

Intervention: DRUG: IN-115314 Ointment 1%

Twice daily(BID), for 56 day

DRUG: IN-115314 Ointment 3%

Twice daily(BID), for 56 day

DRUG: IN-115314 Ointment placebo

Twice daily(BID), IN-115314 Ointment Placebo for 28 days+ IN-115314 Ointment 3% for 28 days...